| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | +71.4% | — |
| R&D Expense | $574K | +80.9% | -42.4% |
| SG&A Expense | $6.9M | +6.2% | +371.9% |
| Operating Income | -$5.3M | +7.4% | -113.5% |
| Net Income | -$1.3M | +87.4% | +29.1% |
| EPS (Basic) | -$0.08 | +87.7% | +74.2% |
| EPS (Diluted) | -$0.30 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.4M | -10.2% | +865.5% |
| Accounts Receivable | $2.8M | +56.9% | — |
| Inventory | $4.5M | +413.7% | — |
| Current Assets | $45.7M | +2.4% | +912.4% |
| Total Assets | $46.3M | +2.6% | +820.9% |
| Current Liabilities | $6.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.5M | — | — |
| Capital Expenditures | $146K | — | — |
| Investing Cash Flow | -$146K | — | — |
| Financing Cash Flow | $513K | — | — |
| Free Cash Flow | -$13.6M | — | — |
| +53.8% |
| +3.2% |
| +124.7% |
| +127.2% |
| Total Liabilities | $12.4M | -6.3% | +55.9% |
| Stockholders' Equity | $33.9M | +6.3% | +1261.6% |